157
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy

Pages 1689-1696 | Received 25 Nov 2010, Accepted 07 Apr 2011, Published online: 12 Jun 2011

References

  • Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC; 2001.
  • Donaldson SS, Hancock SL, Hoppe RT. The Janeway lecture. Hodgkin’s disease--finding the balance between cure and late effects. Cancer J Sci Am 1999;5:325–333.
  • Eghbali H, Raemaekers J, Carde P. The EORTC strategy in the treatment of Hodgkin’s lymphoma. Eur J Haematol Suppl 2005;(66):135–140.
  • Brepoels L, Stroobants S, Verhoef G. PET and PET/CT for response evaluation in lymphoma: current practice and developments. Leuk Lymphoma 2007;48:270–282.
  • Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007;110:3507–3516.
  • Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
  • Hutchings M, Loft A, Hansen M, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006;107:52–59.
  • Gallamini A, Rigacci L, Merli F, et al. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin’s disease. Haematologica 2006;91:475–481.
  • Parkin DM, Plummer M. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 2002;8:57–73.
  • Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69–86.
  • Fritz A, Percy C, Jack A, et al., editors. International Classification of Diseases for Oncology. 3rd ed. Geneva: WHO; 2000.
  • Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004;104:1258–1265.
  • Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.
  • Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002;21:2409–2419.
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–174.
  • Gallamini A, Hutchings M, Rigacci L, et al. Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin’s lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 2007;25:3746–3752.
  • Rigacci L, Zinzani P, Puccini B, et al. Early FDG-PET scan confirms its prognostic impact also in localized stage, ABVD treated Hodgkin lymphoma patients. Haematologica 2010;95(Suppl. 4). Abstract C046.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.